Go to main contents Go to main menus

사용자별 맞춤메뉴

자주찾는 메뉴

추가하기
닫기

Research Articles

contents area

detail content area

Association between APOE ε2 and Aβ burden in patients with Alzheimer- and Vascular-Type Cognitive Im
  • Date2021-02-23 16:01
  • Update2021-02-23 16:01
  • CountersignatureDivision of Research Planning
  • Tel043-719-8033

Neurology, 2020.95(17), e2354-e2365, DOI: https://doi.org/10.1212/WNL.0000000000010811.


Association between APOE ε2 and Aβ burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment

Jin San Lee, Hyejoo Lee; Seongbeom Park; Yeongsim Choe; Yu Hyun Park; Bo Kyoung Cheon; Alice Hahn; Rik Ossenkoppele; Hee Jin Kim; Seonwoo Kim; Heejin Yoo; Hyemin Jang; Soo Hyun Cho; Seung Joo Kim; Jun Pyo Kim; Young Hee Jung; Key-Chung Park; Charles DeCarli; Michael Weiner; Duk L. Na; and Sang Won Seo


Abstract

    Objective: To investigate the association between APOE genotype and β-amyloid (Aβ) burden, as measured by PET in patients with subcortical vascular cognitive impairment (SVCI) and those with Alzheimer disease-related cognitive impairment (ADCI).
    Methods: This was a cross-sectional study of 310 patients with SVCI and 999 with ADCI. To evaluate the effects of APOE genotype or diagnostic group on Aβ positivity, we performed multivariate logistic regression analyses. Further distinctive underlying features of latent subgroups were examined by employing a latent class cluster analysis approach.
    Results: In comparison with ε3 homozygotes, in the ADCI group, ε2 carriers showed a lower frequency of Aβ positivity (odds ratio [OR] 0.43, 95% confidence interval [CI] 0.23-0.79), while in the SVCI group, ε2 carriers showed a higher frequency of Aβ positivity (OR 2.26, 95% CI 1.02-5.01). In particular, we observed an interaction effect of ε2 carrier status and diagnostic group on Aβ positivity (OR 5.12, 95% CI 1.93-13.56), in that relative to ε3 homozygotes, there were more Aβ-positive ε2 carriers in the SVCI group than in the ADCI group. We also identified latent subgroups of Aβ-positive APOE ε2 carriers with SVCI and Aβ-positive APOE ε4 carriers with ADCI.
    Conclusions: Our findings suggest that APOE ε2 is distinctly associated with Aβ deposition in patients with SVCI and those with ADCI. Our findings further suggest that there is a distinctive subgroup of Aβ-positive APOE ε2 carriers with SVCI among patients with cognitive impairment.



  • 본 연구는 질병관리본부 연구개발과제연구비를 지원받아 수행되었습니다.
  • This research was supported by a fund by Research of Korea Centers for Disease Control and Prevention.


This public work may be used under the terms of the public interest source This public work may be used under the terms of the public interest source
TOP